Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia

Completed · Phase 2

Conditions studied: Enteric Hyperoxaluria, Primary Hyperoxaluria, Hyperoxalemia

In brief

Evaluate the efficacy and safety of ALLN-177 in reducing plasma and urinary oxalate levels in adult and pediatric patients with enteric hyperoxaluria and hyperoxalemia or primary hyperoxaluria

Key facts

Study ID
NCT03391804
Run by
Allena Pharmaceuticals
People needed
15
Starts
2018-07-17
Expected to finish
2019-12-13
Last updated by the study team
2020-12-30

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.